Shnyder SD - Search Results

1

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.

Harvey TJ, Burdon D, Steele L, Ingram N, Hall GD, Selby PJ, Vile RG, Cooper PA, Shnyder SD, Chester JD. Harvey TJ, et al. Among authors: shnyder sd. Gene Ther. 2010 Aug;17(8):1000-10. doi: 10.1038/gt.2010.45. Epub 2010 Apr 22. Gene Ther. 2010. PMID: 20410926 Free PMC article.

2

A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer.

Ortega Duran M, Shaheed SU, Sutton CW, Shnyder SD. Ortega Duran M, et al. Among authors: shnyder sd. Cells. 2024 Feb 14;13(4):342. doi: 10.3390/cells13040342. Cells. 2024. PMID: 38391955 Free PMC article.

3

Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours.

Holwell SE, Cooper PA, Grosios K, Lippert JW 3rd, Pettit GR, Shnyder SD, Bibby MC. Holwell SE, et al. Among authors: shnyder sd. Anticancer Res. 2002 Mar-Apr;22(2A):707-11. Anticancer Res. 2002. PMID: 12017147

4

Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model.

Shnyder SD, Cooper PA, Pettit GR, Lippert JW 3rd, Bibby MC. Shnyder SD, et al. Anticancer Res. 2003 Mar-Apr;23(2B):1619-23. Anticancer Res. 2003. PMID: 12820431

5

Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.

Shnyder SD, Cooper PA, Gyselinck N, Hill BT, Double JA, Bibby MC. Shnyder SD, et al. Anticancer Res. 2003 Nov-Dec;23(6C):4815-20. Anticancer Res. 2003. PMID: 14981930

6

Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculature.

Shnyder SD, Hasan J, Cooper PA, Pilarinou E, Jubb E, Jayson GC, Bibby MC. Shnyder SD, et al. Anticancer Res. 2005 May-Jun;25(3B):1889-94. Anticancer Res. 2005. PMID: 16158922 Free article.

7

Reducing the cost of screening novel agents using the hollow fibre assay.

Shnyder SD, Cooper PA, Scally AJ, Bibby MC. Shnyder SD, et al. Anticancer Res. 2006 May-Jun;26(3A):2049-52. Anticancer Res. 2006. PMID: 16827143 Free article.

8

The hollow fibre model--facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfare.

Suggitt M, Cooper PA, Shnyder SD, Bibby MC. Suggitt M, et al. Among authors: shnyder sd. Int J Oncol. 2006 Dec;29(6):1493-9. Int J Oncol. 2006. PMID: 17088988

9

Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models.

Shnyder SD, Cooper PA, Millington NJ, Pettit GR, Bibby MC. Shnyder SD, et al. Int J Oncol. 2007 Aug;31(2):353-60. Int J Oncol. 2007. PMID: 17611692

10

Sodium pancratistatin 3,4-o-cyclic phosphate, a water-soluble synthetic derivative of pancratistatin, is highly effective in a human colon tumor model.

Shnyder SD, Cooper PA, Millington NJ, Gill JH, Bibby MC. Shnyder SD, et al. J Nat Prod. 2008 Mar;71(3):321-4. doi: 10.1021/np070477p. Epub 2007 Dec 22. J Nat Prod. 2008. PMID: 18154271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters